Please use this identifier to cite or link to this item:
https://doi.org/10.1186/1532-429X-11-46
| Title: | Recovery of methamphetamine associated cardiomyopathy predicted by late gadolinium enhanced cardiovascular magnetic resonance | Authors: | Lopez, J.E Yeo, K Caputo, G Buonocore, M Schaefer, S |
Keywords: | beta adrenergic receptor blocking agent dipeptidyl carboxypeptidase inhibitor gadolinium pentetate methamphetamine central stimulant agent contrast medium diagnostic agent gadolinium pentetate methamphetamine adult arterial oxygen saturation article blood pressure measurement cardiomyopathy cardiovascular magnetic resonance cardiovascular system examination case report cell damage clinical evaluation contrast enhancement convalescence disease association disease severity emergency ward female heart function heart left ventricle hypertrophy heart muscle cell human medical history nuclear magnetic resonance imaging paroxysmal dyspnea peripheral edema physical examination prediction priority journal prognosis smoking systolic heart murmur thorax radiography tobacco two dimensional echocardiography cardiomyopathy chemically induced disorder electrocardiography fibrosis heart left ventricle function heart muscle hospitalization pathology pathophysiology prediction and forecasting time treatment outcome Adult Cardiomyopathies Central Nervous System Stimulants Contrast Media Electrocardiography Female Fibrosis Gadolinium DTPA Humans Magnetic Resonance Imaging, Cine Methamphetamine Myocardium Predictive Value of Tests Recovery of Function Severity of Illness Index Time Factors Treatment Outcome Ventricular Dysfunction, Left |
Issue Date: | 2009 | Citation: | Lopez, J.E, Yeo, K, Caputo, G, Buonocore, M, Schaefer, S (2009). Recovery of methamphetamine associated cardiomyopathy predicted by late gadolinium enhanced cardiovascular magnetic resonance. Journal of Cardiovascular Magnetic Resonance 11 (1) : 46. ScholarBank@NUS Repository. https://doi.org/10.1186/1532-429X-11-46 | Rights: | Attribution 4.0 International | Abstract: | Methamphetamine is known to cause a cardiomyopathy which may be reversible with appropriate medical therapy and cessation of use. Late gadolinium enhancement cardiovascular magnetic resonance (CMR) has been shown to identify fibrosis in ischemic and non-ischemic cardiomyopathies. We present a case of severe methamphetamine-associated cardiomyopathy in which cardiac function recovered after 6 months. Evaluation by CMR using late gadolinium enhancement was notable for an absence of enhancement, suggesting an absence of irreversible myocyte injury and a good prognosis. CMR may be useful to predict recovery in toxin-associated non-ischemic cardiomyopathies. © 2009 Lopez et al; licensee BioMed Central Ltd. | Source Title: | Journal of Cardiovascular Magnetic Resonance | URI: | https://scholarbank.nus.edu.sg/handle/10635/183272 | ISSN: | 10976647 | DOI: | 10.1186/1532-429X-11-46 | Rights: | Attribution 4.0 International |
| Appears in Collections: | Staff Publications Elements |
Show full item record
Files in This Item:
| File | Description | Size | Format | Access Settings | Version | |
|---|---|---|---|---|---|---|
| 10_1186_1532-429X-11-46.pdf | 2.23 MB | Adobe PDF | OPEN | None | View/Download |
This item is licensed under a Creative Commons License
